NCT04495491

Brief Summary

This study will compare the angle parameters of patients with PACS before and after LPI. The investigators will analyze the results of patients with different angle closure mechanisms before and after LPI, and participants hope to find the structural parameters for predicting the effect of LPI.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2020

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

July 22, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 31, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2021

Completed
Last Updated

July 31, 2020

Status Verified

July 1, 2020

Enrollment Period

6 months

First QC Date

July 22, 2020

Last Update Submit

July 28, 2020

Conditions

Keywords

laser peripheral iridotomyprimary angle closure suspectangle closure mechanism

Outcome Measures

Primary Outcomes (1)

  • the changes in anterior opening distance before and after LPI

    To compare the difference of anterior opening distance after LPI and baseline parameters before LPI. Anterior opening distance, measured on a line perpendicular to the plane of the trabecular surface 500 μm anterior to the scleral spur and extended to meet the surface of the iris

    between the baseline and 1 hour before discharge

Study Arms (3)

Pupillary block group

According to the configurations of angle closure, the pupillary block group is defined as the iris bombe.

Other: pupillary block group

plateau iris group

According to the configurations of angle closure, the plateau iris group is defined as the thickness of the peripheral iris.

Other: plateau iris group

mixed mechanism group

According to the configurations of angle closure, the mixing mechanism group is defined as the iris bombe plus thickening of the peripheral iris.

Other: mixing mechanism group

Interventions

According to the configurations of angle closure, the pupillary block group is defined as the iris bombe.

Pupillary block group

According to the configurations of angle closure, the plateau iris group is defined as the thickness of the peripheral iris.

plateau iris group

According to the configurations of angle closure, the mixing mechanism group is defined as the iris bombe plus thickening of the peripheral iris.

mixed mechanism group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Chinese Patient was diagnosed of primary angle closure angle suspect

You may qualify if:

  • Patient was diagnosed of primary angle closure angle suspect;
  • received ultrasound Biomicroscopy before and after laser peripheral iridotomy;
  • Voluntary participation in this study;
  • Have enough language comprehension ability;
  • Patient or his legal representative has sign the informed consent.

You may not qualify if:

  • severe health problems resulting in a life expectancy of less than 1 year;
  • previous intraocular surgery or penetrating eye injury;
  • media opacity preventing laser peripheral iridotomy;
  • Researchers think not suitable to participate in this clinical trial subjects;
  • Refused to sign the informed consent.;
  • There are important viscera function failure or other serious disease, including clinical related coronary artery disease, cardiovascular disease or myocardial infarction into the group of the first six months; serious neurological or psychiatric illness; serious infections; coagulant function abnormality; general active infectious diseases; malignant tumor; serious immune diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Ophthalmic Center, Sun Yat-San Univerdity

Guangzhou, Guangdong, China

RECRUITING

Related Publications (3)

  • He M, Jiang Y, Huang S, Chang DS, Munoz B, Aung T, Foster PJ, Friedman DS. Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial. Lancet. 2019 Apr 20;393(10181):1609-1618. doi: 10.1016/S0140-6736(18)32607-2. Epub 2019 Mar 14.

    PMID: 30878226BACKGROUND
  • He M, Friedman DS, Ge J, Huang W, Jin C, Lee PS, Khaw PT, Foster PJ. Laser peripheral iridotomy in primary angle-closure suspects: biometric and gonioscopic outcomes: the Liwan Eye Study. Ophthalmology. 2007 Mar;114(3):494-500. doi: 10.1016/j.ophtha.2006.06.053. Epub 2006 Nov 21.

    PMID: 17123610BACKGROUND
  • He M, Foster PJ, Ge J, Huang W, Zheng Y, Friedman DS, Lee PS, Khaw PT. Prevalence and clinical characteristics of glaucoma in adult Chinese: a population-based study in Liwan District, Guangzhou. Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2782-8. doi: 10.1167/iovs.06-0051.

    PMID: 16799014BACKGROUND

MeSH Terms

Conditions

Glaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Study Officials

  • Mingkai Lin, MD

    Zhongshan Ophthalmic Center, Sun Yat-San University

    STUDY CHAIR

Central Study Contacts

Yuying Zhou, Master

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
4 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
chief physician

Study Record Dates

First Submitted

July 22, 2020

First Posted

July 31, 2020

Study Start

July 1, 2020

Primary Completion

December 31, 2020

Study Completion

March 31, 2021

Last Updated

July 31, 2020

Record last verified: 2020-07

Locations